Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Neuronetics Inc (STIM) Q1 2026 Earnings Call Transcript
Neuronetics reported Q1 2026 results highlighting an 86% revenue surge to $41.8 million, driven largely by the integration of Greenbrook clinic operations. The company posted a net loss of $7.2 million, but achieved positive operating cash flow in the fourth quarter and improved EBITDA. Management announced a leadership change, naming Dan Reavers as President and CEO effective March 23, while Keith Sullivan will support the transition. Forward‑looking guidance projects total 2026 revenue of $160‑$166 million and outlines continued clinic growth, a modest dip in gross margin, and ongoing development of the COMP360 psilocybin therapy.
Ocugen Inc (OCGN) Q1 2026 Earnings Call Transcript
Ocugen reported major clinical progress across its gene‑therapy pipeline, completing enrollment for the OCU400 Phase 3 Limelight trial and delivering strong 12‑month efficacy data for OCU410 in geographic atrophy and OCU410ST in Stargardt disease. The company announced a rolling Biologics License...
AtriCure Inc (ATRC) Q1 2026 Earnings Call Transcript
AtriCure reported $534.5 million revenue for 2025, a 15% increase year‑over‑year, with adjusted EBITDA rising to $61.8 million and cash generation of $45 million. Gross margin held steady at 75% and the company launched two new products, the AtriClip Pro Mini and Cryo XT...
Exelixis Inc (EXEL) Q1 2026 Earnings Call Transcript
Exelixis reported first‑quarter 2026 revenue of $611 million, driven by an $555 million cabozantinib franchise that grew 8% year‑over‑year and lifted global sales to $764 million, a 12.5% increase. The company posted record new patient starts for CABOMETYX, expanding its renal cell carcinoma...
Supernus Pharmaceuticals Inc (SUPN) Q1 2026 Earnings Call Transcript
Supernus Pharmaceuticals announced FDA approval of Qelbree, a non‑controlled ADHD medication for children aged 6‑17, with a U.S. launch planned for the second quarter of 2021. The company reported first‑quarter revenue of $130.9 million, a 38% year‑over‑year increase, driven by growth...
Adaptive Biotechnologies Corp (ADPT) Q1 2026 Earnings Call Transcript
Adaptive Biotechnologies reported $277 million total revenue for 2025, a 55% year‑over‑year increase, driven by a 46% jump in MRD revenue to $212 million and a 43% rise in clonoSEQ test volume to 30,038. Average selling price per test climbed 17% to...
Fasting Opens a Metabolic Window that Favors Anti-Tumor Immunity
Short‑term fasting reshapes the tumor microenvironment by temporarily increasing intratumoral isoleucine, creating a metabolic niche that cytotoxic CD8⁺ T cells can exploit. The study by Chen et al. shows that a 16‑hour fast elevates isoleucine levels, enhancing T‑cell effector programs and...
Neurocrine Biosciences Inc (NBIX) Q1 2026 Earnings Call Transcript
Neurocrine Biosciences reported Q1 2026 results with total product sales exceeding $2.8 billion, a 22% year‑over‑year increase driven by strong performance of INGREZZA and the first‑year launch of CRENESSITY. INGREZZA generated over $2.5 billion, up 9%, while CRENESSITY posted more than $300 million, covering...
AI in Cancer Research Waits for Its Funding Moment
General‑purpose AI attracted $33.9 billion in 2024, while the AI‑in‑cancer market was valued at $2.45 billion, just 7 % of that total. Researchers at the University of Hong Kong unveiled MorphoGenie, an unsupervised deep‑learning tool that extracts subtle patterns from cell images, following...
Vertex Drops mRNA Cystic Fibrosis Program over 'Tolerability' Issues
Vertex Pharmaceuticals announced it is halting development of its mRNA‑based cystic fibrosis (CF) therapy after encountering tolerability and delivery challenges. The decision follows similar setbacks at other biotech firms pursuing mRNA treatments for CF. Vertex will refocus resources on its...
Oklahoma Amends Medical Marijuana Law: Employers Lose Discretion to Designate ‘Safety-Sensitive’ Positions
Oklahoma’s medical‑marijuana statute has been amended by House Bill 3127 to impose a zero‑tolerance drug and alcohol standard for employees in designated “safety‑sensitive” positions. The amendment removes employer discretion in defining those roles, limiting the definition to nine specific duties...
DOJ Moves Certain Marijuana Products to Schedule III, Sets June Rescheduling Hearing
The U.S. Department of Justice issued an order on April 22, 2026 moving FDA‑approved and state‑licensed medical marijuana products into Schedule III of the Controlled Substances Act. A separate order sets a June 29, 2026 hearing to consider broader rescheduling of marijuana from Schedule I to...
All-or-Nothing: Inside CMS Audits of Nursing Home Quality Measures and Their Impact on Reimbursement and Star Ratings
CMS has launched a new data‑validation audit for nursing homes under the Quality Reporting Program, selecting about 1,500 facilities (roughly 10% of the 15,300 certified homes) in early 2026. Facilities must acknowledge the notice within five business days and submit...
Comer Targets CPT System ‘Complexity,’ Citing Concerns Over Fraud, Rising Health Spending
House Oversight Committee Chairman James Comer warned that the American Medical Association’s Current Procedural Terminology (CPT) code system is overly complex, creating loopholes for fraud and inflating federal health‑care spending. He has asked the Centers for Medicare & Medicaid Services...
The Prognostic Nutritional Index (PNI) and Sepsis-Induced Cardiomyopathy (SCM) Risk in the ICU: A Retrospective Study with L-Shaped Analysis
A retrospective analysis of 200 ICU sepsis patients found that the prognostic nutritional index (PNI) is inversely associated with sepsis‑induced cardiomyopathy (SCM). SCM occurred in 63% of the cohort, with incidence dropping from 83% in the lowest PNI tertile (<31.3)...
Body Mass Index and Dietary Intake as Nutritional Determinants of Sarcopenia in Older Adults
A retrospective study of 360 adults aged 60 and older found that 11.4% met sarcopenia criteria. Lower body‑mass index, reduced daily energy, protein, and dietary fiber intakes were each independently linked to higher odds of sarcopenia after adjusting for age,...
Blood Stem Cells Evade Immune Attack in Aplastic Anemia Through Gene Mutations
Scientists at St. Jude Children’s Research Hospital analyzed 619 aplastic anemia patients and discovered that multiple independent gene mutations in blood stem cells silence the disease‑triggering HLA risk allele, allowing those cells to evade autoimmune attack. Overall, 69% of patients...
State Lawmakers Push Emergency Prep Overhaul in Nursing Homes, Citing Past Saber Facility Fire
Pennsylvania lawmakers introduced a bill that would require nursing homes to share their emergency response plans with local police, fire and rescue agencies. The legislation was spurred by the deadly Saber Healthcare explosion in Bristol, which left three residents dead...
ACR Elects New Officers
The American College of Radiology (ACR) elected Alan H. Matsumoto, MD, MA, FACR, as president and David Larson, MD, MBA, FACR, as vice president during its May 4, 2026 annual meeting in Washington, D.C. Matsumoto, the outgoing chair of the Board of...
Early Field Observations Provide Preliminary Consistency with Prior Concerns on Neonatal Outcomes in Gaza
Recent field reports from Gaza indicate a sharp rise in adverse neonatal outcomes, with congenital malformations reportedly doubling and stillbirths increasing by roughly 140% between 2022 and 2025. The observations, cited by Al Jazeera and local health authorities, align with...
CDC Director Echoes Vaccine Aluminum Risks Amid Sc
Well, thankfully the CDC Director follows me here on X and is speaking out about the dangers of vaccines. Not as much as I would like, but injecting aluminum into your body is never healthy. And we know the OLD...
AHA Podcast: Reducing Stigma in Substance Use Disorder Care
In a recent AHA podcast, three leaders from CommonSpirit Health detailed how the system is tackling stigma around substance‑use disorder (SUD) through education, storytelling, language reform, and grassroots culture change. They explained that shifting terminology, providing staff training, and amplifying...
Webinar to Explore AI Use in Cybersecurity, Health Care Technology
A joint webinar hosted by the American Hospital Association and the Joint Commission will explore how artificial intelligence can strengthen cybersecurity in health‑care settings. The event highlights the newly launched Cyber Resilience Readiness program, recent guidance from CISA and the...
AHA, Joint Commission Announce Cybersecurity Readiness Effort
The American Hospital Association and the Joint Commission unveiled the Cyber Resilience Readiness program, a voluntary initiative designed to help hospitals and health systems sustain safe, quality clinical operations during cyber‑related outages lasting 30 days or more. Unlike traditional IT‑focused...
Beyond Antibiotics: Why the Next Great Medical Battle Is Against Fungus
Drug‑resistant fungi are emerging as a global health crisis, outpacing research and treatment options. Experts led by Prof. Paul Verweij have highlighted a silent surge in resistance across common and invasive infections, from athlete's foot to deadly candidemia. A coalition...
FDA Expectations Create Potential Friction in New Form 483 Response Guidance
The FDA has issued a draft guidance outlining heightened expectations for Form 483 response submissions, emphasizing greater detail and faster turnaround. Cooley’s life‑sciences regulatory chair, Sonia Nath, warned that these demands could generate friction between regulators and manufacturers. She urged...
Pennsylvania Jewish Health Foundation Launches $0 Statewide Teen Mental‑Health Initiative
The Pennsylvania Jewish Health Foundation (JHF) convened more than 50 community organizations covering 61 counties to launch a statewide teen mental‑health initiative. The coalition aims to expand funding, prevention and early‑intervention services as recent data show 37% of Pennsylvania teens...
Magnesium Supplementation Cuts Early Colorectal Cancer Risk in New Trial
Researchers at Vanderbilt University Medical Center reported that a 12‑week, personalized magnesium glycinate regimen reduced early signs of colorectal cancer in 240 adults with prior polyps. The supplement reshaped gut microbes to produce vitamin D locally, offering a novel, non‑sunlight‑dependent...
Coroner Rules 11‑week‑old Azariah Levi's Death Preventable After Parents' Health‑system Mistrust
Coroner Ian Telford concluded that the death of 11‑week‑old Azariah Levi was preventable, citing the parents' deep mistrust of the health system and delayed hospital care. The ruling highlights gaps in parental outreach, antenatal support, and emergency response, prompting calls...
Wearable Technology Impacts Hospice Staff Safety, Satisfaction
Wearable safety devices are gaining traction among home‑based hospice staff, who confront heightened physical and psychosocial risks. Silent Beacon, founded in 2016, offers a wearable with a panic button, location tracking, and instant communication to streamline emergency response. Research cited...
The Fight to Lower Prescription Drug Prices in America #CareTalk
In a May 4 2026 CareTalk episode, host Laura Packard sits with Vinny DeMarco of Maryland Health Care for All to dissect the latest state‑level tactics for lowering prescription‑drug prices. The conversation spotlights Maryland’s $35‑per‑month insulin cap and Colorado’s new drug‑price transparency...
WSJ Calls Trump’s FDA Pick Marty Makary a Potential Disaster for Drug Approvals
The Wall Street Journal warned Sunday that President Donald Trump’s FDA nominee, surgeon‑scientist Dr. Marty Makary, could become a disaster for the agency. The editorial cites Makary’s pattern of blocking rare‑disease and gene‑therapy drugs, alleged conflicts of interest, and a...
Medigap Premiums Spike Up to 45% as Medicare Advantage Payments Rise Only 2.7%
Retirees are confronting steep Medigap premium hikes—up to 45% for Chubb policies and 12‑26% across major carriers—while Medicare Advantage plans see a modest 2.7% payment increase from CMS. The diverging trends intensify the choice between supplemental coverage and private Medicare...
Mayo Clinic AI Spots Pancreatic Cancer up to 3 Years Early, 73% Sensitivity
Researchers at the Mayo Clinic unveiled an AI model that can flag pancreatic cancer up to three years before it appears on conventional scans, achieving a 73% sensitivity rate—nearly twice that of board‑certified radiologists. The breakthrough could reshape early‑detection pathways...
Utilization of Modern Family Planning Methods and Associated Factors Among Men Aged 15- 54 Years in Pakwach District Uganda: A...
A cross‑sectional survey of 302 men aged 15‑54 in Pakwach District, Uganda, found that only 45.4% reported using condoms and none had undergone vasectomy, indicating very low modern family‑planning (FP) uptake. Logistic regression identified three significant predictors: comfort discussing FP...
SimonMed Deploys AIRS Medical to Power AI-Enhanced MRI Across National Network
SimonMed, a leading independent outpatient imaging provider, announced the enterprise‑wide deployment of AIRS Medical’s FDA‑cleared SwiftMR AI solution across its national MRI network. The AI platform promises sharper images, up to 30% faster scan times, and consistent performance on multi‑vendor...
Leroy Hood Unveils Dark Proteome Frontier at SynBioBeta 2026
“I am interested in deciphering human complexity in terms of wellness and disease. I guess you would describe me as a multi-disciplinary human biologist.” That is Dr. Lee Hood @ISBLeeHood in one quote. We're excited and honored to have Dr. Leroy Hood...
AI's Echo Chamber: Validation Vs. Reassurance in Healthcare
One of the biggest problems with AI is it so often tells us what we want to hear. In healthcare, I can’t figure out if that means telling a patient they have a likely diagnosis — or that they don’t....
Israeli Team to Perform First Nanotech Spinal‑Cord Implant in Human Trial
Professor Tal Dvir of Tel Aviv University will lead the world’s first human implantation of a nanotech‑enhanced spinal‑cord scaffold, slated for surgery in the coming weeks. The Health Ministry has cleared compassionate‑use trials for eight patients, following mouse studies that...
FDA Likely to Fast‑Track KRAS Drug for PR Boost
To try to offset this, I predict the FDA will approve the $RVMD KRAS drug in record time. Not just much quicker than usual. FDA needs a public relations win, and this will be their vehicle.
Gene Therapy Targets Childhood Blindness by Fixing Retinal Gene
Jean Bennett and Albert Maguire developed a gene therapy approach to correct a gene in the retina to treat childhood blindness. https://t.co/WJ99qvcUT1
New Report Finds 75% of Women Skip Healthcare Due to Scheduling Constraints
Teal Health’s State of Her Health 2026 report reveals that 75% of U.S. women have likely skipped a medical appointment because it didn’t fit into their schedules, and 55% say they definitely have. The survey of more than 500 women...
Invest in Biosecurity Now to Counter AI and Pandemic Threats
We should absolutely take AI risks to biosecurity seriously. And we shouldn't panic. Now is the time to strengthen our overall biosecurity regime. The same investments in monitoring, preparation, and technology development will reduce risk from natural pandemics, lab leaks,...
Confluent Medical Technologies Opens Nitinol Wire Manufacturing Facility in India
Confluent Medical Technologies has launched a 26,000‑square‑foot Nitinol Wire Center of Excellence in Hyderabad, India, effectively doubling its nitinol wire output. The ISO 13485‑certified facility offers four‑week lead times for wire diameters ranging from 0.004 in. to 0.100 in. with ultra‑tight tolerances. By...
Clene Secures FDA Pathway to File Accelerated‑Approval NDA for ALS Drug CNM‑Au8
Clene Inc. announced it will submit an accelerated‑approval New Drug Application for its ALS therapy CNM‑Au8 in the third quarter of 2026, following a FDA Type C meeting that said the company’s data could support the pathway. The filing hinges...
Delayed hCG Trigger Does Not Improve Oocyte Maturation Rate: Evidence From 9,319 IVF/ICSI Cycles Using Three Controlled Ovarian Hyperstimulation Protocols
A retrospective cohort of 9,319 first‑time IVF/ICSI cycles in China examined whether the proportion of dominant follicles at hCG trigger influences oocyte maturation. Across depot GnRHa, long GnRHa, and antagonist protocols, overall DFP showed no significant impact on maturation rates,...
Surgical Malpractice Lawyer
Surgical malpractice lawyers help victims of operating‑room errors secure compensation and hold negligent providers accountable. Common claims involve wrong‑site surgery, retained instruments, anesthesia mistakes, and post‑operative neglect. Attorneys must prove duty, breach, causation, and damages using medical records and expert...
FDA Clears Custom Titanium Cranial Implant for Skull Repair
The U.S. FDA granted 510(k) clearance to CGBIO’s EASYMADE TI, a patient‑specific titanium cranial and craniofacial implant made via laser powder‑bed fusion. The device is designed from each patient’s CT scan, manufactured in South Korea and shipped to U.S. hospitals within...
More OMQ Letters After FDA Inspections? Don't Treat Them as Noise
Pharmaceutical manufacturers are receiving more post‑inspection letters from the FDA’s Office of Manufacturing Quality (OMQ), even after inspections with only one or two Form FDA 483 observations. The rise aligns with a 27% jump in FY2024 drug quality inspections—62% of...
The Challenges of Independent Rural Healthcare Practices
Independent rural healthcare practices are grappling with mounting financial pressures, especially from Medicaid’s cumbersome administrative requirements and thin reimbursement rates. Staffing shortages and limited access to capital further restrict their ability to adopt new technologies or expand services. The shift...